Patents by Inventor Florian von Raison

Florian von Raison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE REGIMEN FOR A NR2B-NMDA RECEPTOR NAM FOR THE TREATMENT OF DEPRESSION
    Publication number: 20240041853
    Abstract: The invention relates to a dosage regimen of Compound (I), or a pharmaceutically acceptable salt thereof, for the treatment of diseases or disorders mediated by negative allosteric modulation or inhibition of NR2B-NMDA receptor including, but not limited to, major depressive disorder, treatment resistant depression and suicidality. The invention also relates to the use of Compound (I), or a pharmaceutically acceptable salt thereof, in the treatment of major depressive disorder in patients with suicidal ideation with intent.
    Type: Application
    Filed: December 3, 2021
    Publication date: February 8, 2024
    Inventors: Jang-Ho CHA, Thomas FALLER, Baltazar GOMEZ-MANCILLA, Dimitris PAPANICOLAOU, Carman-Gabriela SERBAN, Florian VON RAISON
  • Electronic Devices and Methods for Treatment of Depressive Symptoms, Depressive Disorders Utilizing Digital Therapies
    Publication number: 20200335191
    Abstract: The present disclosure relates to uses of computerized behavioral therapy in the treatment of depressive symptoms or depressive disorder associated with multiple sclerosis.
    Type: Application
    Filed: April 13, 2020
    Publication date: October 22, 2020
    Applicants: Pear Therapeutics, Inc., Novartis AG
    Inventors: Michael Brown, Brent Paul Kersanske, Kenneth R. Weingardt, Jillian Christine Ahrens, Seyyed Nassir Ghaemi, Alexandra Kubara, Florian von Raison